Meeting summary - Medicine shortages SPOC working party meeting 15 July 2026

Human medicines European public assessment report (EPAR): Degevma, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised

European Medicines Agency workshop on bacteriophage therapy, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 October 2026, 09:00 (CET) to 30 October 2026, 18:00 (CET)

Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2026, 09:00 (CET) to 20 November 2026, 13:00 (CET)

Advice on ‘end-of-year’ submission dates for type I variations in 2026

EMA Management Board: highlights of September 2026 meeting

Proceedings for the nomination and appointment of the next EMA Executive Director

Human medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised

International Coalition of Medicines Regulatory Authorities (ICMRA)

Global regulators call for advancing alternatives to animal testing across the medicine lifecycle